Analyst Rating Changes — Upgrades, Downgrades & Price Targets

53044 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Aug 13 00:18 UTC	NEXN Nexxen International	◎ Target	Needham & Company LLC	Laura Martin ★★★☆☆ #1770	Buy	$10.50→ $13.00+23.8%
Aug 13 00:18 UTC	NEO Neo Performance Materials	◎ Target	Stifel Nicolaus	firm only	Buy	C$49.00→ C$55.00+12.2%
Aug 13 00:18 UTC	NEM Newmont	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2297	Outperform	$147.00→ $149.00+1.4%
Aug 13 00:18 UTC	NEM Newmont	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2297	Sec→ r Outperform	$147.00→ $149.00+1.4%
Aug 13 00:18 UTC	NEM Newmont	◎ Target	TD	firm only	Buy	$127.00→ $133.00+4.7%
Aug 13 00:18 UTC	NA National Bank of Canada	◎ Target	TD	firm only	Hold	C$202.00→ C$227.00+12.4%
Aug 13 00:18 UTC	NA National Bank of Canada	◎ Target	Raymond James Financial	firm only	Market Perform	C$203.00→ C$226.50+11.6%
Aug 13 00:18 UTC	MTZ MasTec	◎ Target	The Goldman Sachs Group	Ati Modak not yet tracked	Buy	$508.00→ $409.00-19.5%
Aug 13 00:18 UTC	MSFT Microsoft	◎ Target	Wells Fargo & Company	Michael Turrin ★★★☆☆ #1104	Overweight	$650.00→ $700.00+7.7%
Aug 13 00:18 UTC	MPLX Mplx	◎ Target	Morgan Stanley	Robert Kad ★★★☆☆ #1029	Equal Weight	$60.00→ $66.00+10.0%
Aug 13 00:18 UTC	MOBI Mobia Medical	◎ Target	JPMorgan Chase & Co.	Robbie Marcus ★★★★★ #307	Overweight	$15.00→ $17.00+13.3%
Aug 13 00:18 UTC	MNPR Monopar Therapeutics	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2206	Buy	$117.00→ $133.00+13.7%
Aug 13 00:18 UTC	MLCO Melco Resorts & Entertainment	◎ Target	Susquehanna	Joseph Stauff ★★★☆☆ #2119	Positive	$12.00→ $8.00-33.3%
Aug 13 00:18 UTC	MIDD Middleby	◎ Target	JPMorgan Chase & Co.	Tami Zakaria ★★★☆☆ #1047	Neutral	$151.00→ $141.00-6.6%
Aug 13 00:18 UTC	MFIC MidCap Financial Investment	◎ Target	Royal Bank Of Canada	Kenneth S. Lee not yet tracked	Sec→ r Perform	$11.00→ $10.00-9.1%
Aug 13 00:18 UTC	MDLN Medline	◎ Target	JPMorgan Chase & Co.	Lisa Gill ★★★★☆ #904	Overweight	$53.00→ $46.00-13.2%
Aug 13 00:18 UTC	MDB MongoDB	◎ Target	Oppenheimer	Ittai Kidron ★★★★☆ #368	Outperform	$410.00→ $475.00+15.9%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	Stifel Nicolaus	firm only	Buy	C$18.00→ C$21.00+16.7%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	Scotiabank	firm only	Sec→ r Outperform	C$19.00→ C$20.00+5.3%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	ATB Cormark Capital Markets	firm only	Outperform	C$19.00→ C$22.00+15.8%
Aug 13 00:18 UTC	MASS 908 Devices	◎ Target	Stifel Nicolaus	Daniel Arias ★★★★★ #28	Buy	$10.00→ $12.00+20.0%
Aug 13 00:18 UTC	MASS 908 Devices	◎ Target	Roth Capital	Max Masucci not yet tracked	Buy	$11.00→ $13.00+18.2%
Aug 13 00:18 UTC	MAA Mid-America Apartment Communities	◎ Target	Morgan Stanley	Adam Kramer ★★★☆☆ #1522	Overweight	$155.00→ $147.00-5.2%
Aug 13 00:18 UTC	LQDA Liquidia	◎ Target	BTIG Research	Julian Harrison ★★☆☆☆ #2847	Buy	$109.00→ $111.00+1.8%
Aug 13 00:18 UTC	LQDA Liquidia	◎ Target	Needham & Company LLC	Serge Belanger ★★★☆☆ #1774	Buy	$70.00→ $110.00+57.1%
Aug 13 00:18 UTC	LOW Lowe's Companies	◎ Target	Royal Bank Of Canada	Steven Shemesh ★★★★☆ #947	Sec→ r Perform	$232.00→ $231.00-0.4%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	TD Cowen	Sean O'Loughlin ★★☆☆☆ #2272	Hold	$800.00→ $820.00+2.5%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	JPMorgan Chase & Co.	Joseph Cardoso ★★☆☆☆ #2278	Overweight	$1,165.00→ $1,280.00+9.9%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Bank of America	Vivek Arya ★★☆☆☆ #2751	Neutral	$1,100.00→ $1,000.00-9.1%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Morgan Stanley	Meta Marshall ★★★☆☆ #1277	Equal Weight	$900.00→ $1,000.00+11.1%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Mizuho	Vijay Rakesh ★★☆☆☆ #2361	Outperform	$1,100.00→ $1,140.00+3.6%
Aug 13 00:18 UTC	LENZ LENZ Therapeutics	◎ Target	Piper Sandler	Biren Amin ★☆☆☆☆ #3102	Neutral	$12.00→ $7.00-41.7%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Morgan Stanley	Matthew Harrison not yet tracked	Overweight	$48.00→ $49.00+2.1%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Royal Bank Of Canada	Leonid Timashev ★★★☆☆ #1398	Outperform	$59.00→ $58.00-1.7%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	TD Cowen	Yaron Werber ★★☆☆☆ #2347	Hold	$29.00→ $24.00-17.2%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Barclays	Etzer Darout ★★★☆☆ #979	Overweight	$80.00→ $78.00-2.5%
Aug 13 00:18 UTC	LEG Leggett & Platt	◎ Target	Piper Sandler	Peter Keith ★★★★☆ #544	Neutral	$12.00→ $10.00-16.7%
Aug 13 00:18 UTC	LDOS Leidos	◎ Target	The Goldman Sachs Group	Gavin Parsons ★★★☆☆ #1665	Neutral	$152.00→ $132.00-13.2%
Aug 13 00:18 UTC	LBRX LB Pharmaceuticals	◎ Target	BMO Capital Markets	Malcolm Hoffman not yet tracked	Outperform	$46.00→ $54.00+17.4%
Aug 13 00:18 UTC	LAR Lithium Americas (Argentina)	◎ Target	Scotiabank	Ben Isaacson ★★★☆☆ #2084	Sec→ r Outperform	$10.00→ $9.50-5.0%
Aug 13 00:18 UTC	LAMR Lamar Advertising	◎ Target	Wells Fargo & Company	Steven Cahall ★★★★☆ #472	Equal Weight	$150.00→ $151.00+0.7%
Aug 13 00:18 UTC	KSPI Joint Stock Company Kaspi.kz	◎ Target	Susquehanna	James Friedman ★★★☆☆ #1539	Neutral	$95.00→ $100.00+5.3%
Aug 13 00:18 UTC	KRNT Kornit Digital	◎ Target	Needham & Company LLC	James Ricchiuti ★★☆☆☆ #2383	Buy	$22.00→ $23.00+4.5%
Aug 13 00:18 UTC	KNTK Kinetik	◎ Target	Truist Financial	Gabe Daoud not yet tracked	Buy	$53.00→ $59.00+11.3%
Aug 13 00:18 UTC	JRVR James River Group	◎ Target	Truist Financial	Mark Hughes ★★★★☆ #809	Hold	$6.00→ $5.00-16.7%
Aug 13 00:18 UTC	JBS JBS	◎ Target	JPMorgan Chase & Co.	Lucas Ferreira ★★★☆☆ #1811	Overweight	$18.00→ $17.50-2.8%
Aug 13 00:18 UTC	JBI Janus International Group	◎ Target	UBS Group	John Lovallo ★★★☆☆ #1945	Neutral	$6.00→ $5.60-6.7%
Aug 13 00:18 UTC	IPI Intrepid Potash	◎ Target	UBS Group	Joshua Spector ★★★☆☆ #1605	Sell	$26.00→ $29.00+11.5%
Aug 13 00:18 UTC	IPHA Innate Pharma	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2206	Buy	$8.00→ $9.00+12.5%
Aug 13 00:18 UTC	INTC Intel	◎ Target	UBS Group	Timothy Arcuri ★★★☆☆ #1965	Neutral	$121.00→ $112.00-7.4%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!